How Much Revenue North America Breast Reconstruction Market Will Generate Globally Till 2030

Posted by Mrudula Karmarkar on October 13th, 2022

The North America breast reconstruction market size is anticipated to reach USD 366.27 million by 2030, registering a CAGR of 6.69% during the forecast period, according to a new report by Grand View Research, Inc. This can be credited to the increase in number of breast cancer patients within this region. For instance, as per the Canadian Cancer Society 2022, one in eight females is expected to be diagnosed with breast cancer. Moreover, as per a similar source, breast cancer is the second most occurring cancer in Canada. Thus, the increasing number of breast cancer patients in Canada is predicted to boost the North America Breast Reconstruction market.

Moreover, the number of breast reconstruction surgery is also increasing in this region. For instance, as per the Archives of Plastic Surgery, post-mastectomy breast reconstruction surgery has increased from 19.4% in 2015 to 53.4% in 2018. Similarly, as per the Canadian Cancer Society, one in every five women in Canada goes under breast reconstruction post-mastectomy. Thus, a rise in the number of breast reconstruction surgery is anticipated to drive the North America breast reconstruction market. Furthermore, the initiation of various awareness campaigns is leading to rising awareness among women. For instance, the Breast Reconstruction Awareness Campaign educates, engages & empowers females to take the right decision regarding breast reconstruction, post breast cancer diagnosis.

The North America breast reconstruction market witnessed a dip due to COVID-19. However, post-pandemic, the market is projected to have a significant growth rate. Elective surgeries such as breast augmentation, which were postponed during COVID-19, are expected to be held in the post-COVID-19 period. Moreover, to capture the market, many companies are entering into various strategies such as geographic expansion, product launches, and partnerships.

To Request Sample Copy of this report, click the link:

https://www.grandviewresearch.com/industry-analysis/north-america-breast-reconstruction-market/request/rs1

For instance, in April 2021, Sientra, Inc. and the Butterfly Network announced a strategic partnership to improve diagnostic surveillance of breast implant patients. This was expected to help the company to strengthen its safety profile, which was backed by the Platinum20 warranty program. Therefore, such instances are expected to drive the North America breast reconstruction market in the post-COVID-19 period.

North America Breast Reconstruction Market Report Highlights

• In terms of product, the implants segment held the largest market share of 63.40% in 2021 in the North America breast reconstruction market. However, the tissue expander segment is expected to develop with the fastest growth rate of 6.85% CAGR, during the forecast period. This can be credited to the advancement in the products within the tissue expander segment
• Based on shape, the round shape segment held the largest share of 55.30% in 2021 in the North America breast reconstruction market. However, the anatomical shape is anticipated to witness the fastest growth rate of CAGR of 6.81% during the forecast period
• Based on end-use, the hospital segment was expected to dominate the market with a 55.28% share during 2021. However, the cosmetology clinics segment is projected to witness the highest growth rate of 6.91% CAGR during the forecast period. This can be credited to the rising number of cosmetologists in the North America region.
• Based on the region, the U.S. dominated the North America breast reconstruction market. This can be credited to the increase in number of breast cancer & breast reconstruction procedures within this nation

Rising breast cancer patients and an increase in the number of breast reconstruction surgeries are the major factors driving the market. Moreover, the availability of reimbursement policies with respect to breast reconstruction is further boosting the North America breast reconstruction market. The incidence rate of breast cancer has increased considerably in the past two decades. For instance, as per Cancer.net, from the mid-2000s, invasive breast cancer in women has increased approximately by half a percent every year. Moreover, as per a similar source, it is estimated that 287,850 women in the U.S. are expected to be diagnosed with invasive breast cancer in 2022.

The North America breast reconstruction market is fragmented in nature and has many players in the market. The degree of competition and competitive rivalry among the key players is expected to intensify during this period. Moreover, many market players are opting for several strategies such as product approval, partnership, and mergers to have a competitive edge over its competitor.

For instance, in December 2020, Motiva USA LLC received a CE mark for its next-generation Motive Ergonomicx2 silicone breast implant platform. Additionally, the company also received a CE mark for the Motiva Ergonomix2 Diamond breast implant which is intended to be used with the Motiva MIA system. Similarly, in July 2021, BD acquired Tepha, Inc. This helped BD to use Tepha’s patented resorbable polymer to expand their mesh portfolio’s innovation potential for soft tissue repair, reconstruction & regeneration segments. Thus, with the above-mentioned strategies, the North America breast reconstruction market is likely to propel during the forecast period.

Some of the key players in the North America breast reconstruction market include:

• Mentor Medical Systems B.V. (Johnson & Johnson)
• Abbvie (Allergan Inc.)
• Integra Life sciences Corporation
• Sientra, Inc.
• Ideal Implant Incorporated
• Stryker Corporation
• Establishment Labs Holding, Inc. (Motiva USA LLC)
• RTI Surgical
• MTF Biologics
• SIA (Surgical Innovation Associates)
• Tela Bio, Inc.